ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,572Medicare Part D Prescriptions Filled, Including Refills

Rank: 200 out of 1677

$461K Total Retail Price of All Prescriptions

Rank: 413 out of 1677

913 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 913 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 913 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 10,164 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 1,054 846 1 1
LISINOPRIL 808 680 2 3
OMEPRAZOLE 730 626 3 6
METFORMIN HCL 588 465 4 7
LEVOTHYROXINE SODIUM 575 488 5 5
AMLODIPINE BESYLATE 484 403 6 2
ZOLPIDEM TARTRATE 273 209 7 15
CITALOPRAM HBR 245 205 8 22
HYDROCODONE-ACETAMINOPHEN 225 162 S3 9 4
ATENOLOL 189 139 10 21
FENOFIBRATE 185 142 11 48
FUROSEMIDE 184 152 12 8
ALENDRONATE SODIUM 184 173 12 43
LOSARTAN POTASSIUM 183 170 14 25
DOXAZOSIN MESYLATE 177 168 15 90
FLUTICASONE PROPIONATE 170 126 16 29
VYTORIN 169 127 17 192
TRAMADOL HCL 167 126 18 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 166 135 19 17
HYDROCHLOROTHIAZIDE 164 138 20 9
METOPROLOL TARTRATE 154 136 21 12
PREDNISONE 153 113 22 40
CARVEDILOL 145 124 23 20
RANITIDINE HCL 145 121 23 18
CRESTOR 138 116 25 28
GABAPENTIN 136 103 26 11
MELOXICAM 134 116 27 27
PRAVASTATIN SODIUM 133 116 28 10
DOXYCYCLINE HYCLATE 123 94 29 96
POTASSIUM CHLORIDE 109 85 30 14
DIGOXIN 107 99 31 71
ATORVASTATIN CALCIUM 93 73 32 13
CLONIDINE HCL 86 66 33 36
SERTRALINE HCL 82 60 34 26
CIPROFLOXACIN HCL 82 69 34 57
GLIPIZIDE 78 57 36 56
WARFARIN SODIUM 78 55 36 24
METOCLOPRAMIDE HCL 78 59 36 124
TIZANIDINE HCL 78 38 36 108
TAMSULOSIN HCL 76 65 40 34
FINASTERIDE 74 71 41 130
GLIMEPIRIDE 73 57 42 33
NAPROXEN 67 51 43 87
LOSARTAN-HYDROCHLOROTHIAZIDE 66 56 44 42
FLUOXETINE HCL 63 49 45 49
METRONIDAZOLE 61 51 46 287
VENTOLIN HFA 61 47 46 89
THEOPHYLLINE ANHYDROUS 60 35 48 250
LANTUS 56 43 49 44
NYSTATIN 55 41 50 185
DILTIAZEM ER 53 40 51 143
ALLOPURINOL 51 44 52 31
VERAPAMIL ER 51 39 52 86
METOPROLOL SUCCINATE 51 48 52 23
TRAZODONE HCL 51 47 52 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.